More tools:Markets·Screener·Research·Chat

Adicet Bio, Inc. Common Stock (ACET) Financial Statements

Adicet Bio, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S5NB78
XNAS · usd
9.54▼ 0.20 (-2.00%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close9.73
Day's Range9.38 – 9.97
52-Week Range0.46 – 9.97
Volume81.8K
Avg Volume88.2K
Share Statistics
Shares Outstanding
Employees102
ExchangeXNAS
Listed2020-09-16
Share count as of August 3, 2026
Loading Income Statement…
Key questions about Adicet Bio, Inc. Common Stock (ACET)
What is Adicet Bio, Inc. Common Stock's Market Cap?
Adicet Bio, Inc. Common Stock's Market Cap is $89.3M, based on as-reported figures from SEC (XBRL) filings.
What is Adicet Bio, Inc. Common Stock's Enterprise Value?
Adicet Bio, Inc. Common Stock's Enterprise Value is $56.9M, based on as-reported figures from SEC (XBRL) filings.
What is Adicet Bio, Inc. Common Stock's EV / EBITDA?
Adicet Bio, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Adicet Bio, Inc. Common Stock's Net Income (TTM)?
Adicet Bio, Inc. Common Stock's Net Income (TTM) is -$99.0M, based on as-reported figures from SEC (XBRL) filings.
What is Adicet Bio, Inc. Common Stock's EBITDA?
Adicet Bio, Inc. Common Stock's EBITDA is -$98.1M, based on as-reported figures from SEC (XBRL) filings.
What is Adicet Bio, Inc. Common Stock's Diluted EPS (TTM)?
Adicet Bio, Inc. Common Stock's Diluted EPS (TTM) is -10.57, based on as-reported figures from SEC (XBRL) filings.
What is Adicet Bio, Inc. Common Stock's Net Debt?
Adicet Bio, Inc. Common Stock's Net Debt is -$32.3M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue related party————
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Interest income
Interest expense
Other expense, net
Loss before income tax provision
Income tax provision
Segment net loss
Net loss per share, basic—
Net loss per share, diluted—